日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Revival of Ethionamide by Alpibectir

Alpibectir 的乙硫异烟胺复兴

Pieren, Michel; Dale, Glenn E; Gitzinger, Marc; Tiberi, Simon; Penman, Sophie L; Remuiñán, Modesto J; Dubbelboer, Ilse R; Simonsson, Ulrika S H; Upton, Caryn M; Mabuka, Thabo; Diacon, Andreas H

Population pharmacokinetics of TBAJ-587 and its main metabolites-Evaluation of different loading dose strategies and early dose selection

TBAJ-587及其主要代谢物的群体药代动力学——不同负荷剂量策略和早期剂量选择的评估

Leding, Albin A M; Bruinenberg, Paul; Conradie, Almari; Nedelman, Jerry; Lombardi, Antonio; Hickman, Dean; Simonsson, Ulrika S H

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis

一项评估利福平联合美罗培南加阿莫西林/克拉维酸钾治疗利福平耐药肺结核成人患者的早期杀菌活性的 2a 期研究

de Jager, Veronique; Mockeliunas, Laurynas; You, Huifang; Simonsson, Ulrika S H; Collings, Tarryn; Upton, Caryn M; Bezuidenhout, Johannes A; Gupte, Nikhil; Dorman, Susan E; Nuermberger, Eric; Lamichhane, Gyanu; Diacon, Andreas H; Dooley, Kelly E

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

新冠病毒大流行期间新冠肺炎和呼吸道感染的风险因素

Mockeliunas, Laurynas; van Wijk, Rob C; Upton, Caryn M; Peter, Jonathan; Diacon, Andreas H; Simonsson, Ulrika S H

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

耐药结核病治疗中利奈唑胺相关不良事件安全目标的推导和临床应用

Keutzer, Lina; Mockeliunas, Laurynas; Sturkenboom, Marieke G G; Bolhuis, Mathieu S; Akkerman, Onno W; Simonsson, Ulrika S H

Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium.

在 ERA4TB 联盟内实施结核分枝杆菌体外试验数据生成和报告的最佳实践

van Wijk Rob C, Lucía Ainhoa, Sudhakar Pavan Kumar, Sonnenkalb Lindsay, Gaudin Cyril, Hoffmann Eik, Dremierre Bérénice, Aguilar-Ayala Diana Angélica, Molin Michael Dal, Rybniker Jan, de Giorgi Stefano, Cioetto-Mazzabò Laura, Segafreddo Greta, Manganelli Riccardo, Degiacomi Giulia, Recchia Deborah, Pasca Maria Rosalia, Simonsson Ulrika S H, Ramón-García Santiago

Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients

基于模型的成人和儿童B型血友病患者达尔西那考格α预防性治疗剂量选择支持

Faraj, Alan; Le Moan, Natacha; Gorina, Eduard; Blouse, Grant E; Knudsen, Tom; Simonsson, Ulrika S H

Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy

基于模型指导的马泽普塔考格α(活化)儿科剂量选择:一种暴露匹配策略

Faraj, Alan; van Wijk, Rob C; Neuman, Linda; Desai, Shraddha; Blouse, Grant E; Knudsen, Tom; Simonsson, Ulrika S H

Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

利用马尔可夫链模型量化季节性对包括 COVID-19 在内的呼吸道感染严重程度的影响

van Wijk, Rob C; Mockeliunas, Laurynas; Upton, Caryn M; Peter, Jonathan; Diacon, Andreas H; Simonsson, Ulrika S H

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial

美罗培南联合克拉维酸钾(含或不含利福平)治疗结核病的早期杀菌活性:COMRADE随机2A期临床试验

De Jager, Veronique; Gupte, Nikhil; Nunes, Silvia; Barnes, Grace L; van Wijk, Rob Christiaan; Mostert, Joni; Dorman, Susan E; Abulfathi, Ahmed A; Upton, Caryn M; Faraj, Alan; Nuermberger, Eric L; Lamichhane, Gyanu; Svensson, Elin M; Simonsson, Ulrika S H; Diacon, Andreas H; Dooley, Kelly E